Cargando…
Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report
RATIONALE: Prostate cancer along with colorectal and lung cancers accounts for 42% of cancer cases in men globally. It is the first cancer indication for which the use of active immunotherapy, Sipuleucel-T (Provenge) was granted by the FDA in 2010. This study presents a case of prostate carcinoma an...
Autores principales: | Sharan, Bandana, Chiliveru, Srikanth, Bagga, Jasmine, Kohli, Sakshi, Bharadwaj, Asmi, Vaid, Ashok K., Kumar, Chaitanya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034657/ https://www.ncbi.nlm.nih.gov/pubmed/32080073 http://dx.doi.org/10.1097/MD.0000000000018889 |
Ejemplares similares
-
Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN(®) in combination with chemotherapy
por: Kumar, Chaitanya, et al.
Publicado: (2019) -
Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN
(®) (dendritic cell‐based vaccine): a case report
por: Kumar, Chaitanya, et al.
Publicado: (2017) -
A highly malignant case of neuroblastoma with substantial increase of single-nucleotide variants and normal mismatch repair system: A case report
por: Yuan, Lin-Qing, et al.
Publicado: (2017) -
A case report of apatinib in treating osteosarcoma with pulmonary metastases
por: Zhou, Yong, et al.
Publicado: (2017) -
Brain metastases from esophageal cancer: A case report
por: Qie, Shuai, et al.
Publicado: (2020)